male hypogonadism
Endocrinology · 2005–2021
3decisions
3medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| follitropin alfa Treatment of anovulatory infertility in women unresponsive to clomiphene citrate, controlled ovarian hyperstimulation in women undergoing assisted reproductive… | Jul 2021 | Recommended with restriction | input received IVF Directors Group |
| testosterone Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests, with scrotal… | Mar 2021 | Recommended | no section in document |
| testosterone undecanoate Testosterone replacement in primary and secondary male hypogonadism, including androgen deficiency in males with established pituitary or testicular disorders,… | Nov 2005 | Recommended with restriction | no section in document |
Who spoke
IVF Directors Group
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.